Market Size and Growth
The market size of the global intravenous infusion pump is estimated at USD 6.72 billion in the year 2025 and is estimated to rise by USD 7.25 billion in 2026 to an estimate of USD 14.02 billion in 2035 at a CAGR of 7.6% between the years 2026 and 2035.
Intravenous Infusion Pump Market Revenue and Trends
The intravenous infusion pumps market encompasses the volumetric, syringe, ambulatory, and smart pumps, which have been used in the accurate delivery of fluids, medication, nutrients, and chemotherapy in both hospital and home care settings. Its market size in the world is surging in intravenous infusion pumps, as new technologies in healthcare in most countries around the world are expanding via increased chronic diseases such as cancer, diabetes, aging population, surgical procedures and hospitalization, and decreasing dose errors and smart pumps connectivity, among others.
What are the Factors That Have a Significant Contribution to the Growth of the intravenous infusion pump market?
The increase in chronic care patients who need long-term IV treatment including oncological care, diabetes care, and pain care, and the rise in patient hospitalization and the necessity of precise medication delivery, has increased the demand of infusion pump products. It has been reported that chronic diseases impact hundreds of millions of people across the world, and the number of cancer and diabetes cases still increases at a sharply rising rate. With the increasing elderly population, patients will also demand high quality and safe pumps to administer chemotherapy, parenteral nutrition and home infusion therapies.
The technological advancements have brought in intelligent pumps with AI-based dose error minimization software, electronic health record interoperability, wireless connectivity, and portability, thus enhancing the safety, precision and efficiency of clinicians. Other motivators are increased focus on preventing medication errors, more homecare and ambulatory treatments, positive reimbursement policies, and government programs that support advanced healthcare facilities in the developed and emerging markets.
Segment Insight
By Product Type
The largest portion of the intravenous infusion pump market, in 2025, was occupied by products that are volumetric in nature and need large volume devices that have the capability to supply and administer fluids, medications, and nutrients at regulated rates. These pumps are needed in general hospital use, critical care, and continuous therapy control, and innovations in smart and interoperable volumetric systems (commonly known as reliable by clinicians in high-volume infusions and less dosing mistakes) have a profound effect.
By Distribution Channel
Hospital procurement and direct sales channels occupy the largest market share and present the main source of advanced equipment, integration services, training, and regulatory compliance. These channels are the expert support, the customization, and the maintenance of the facility that deals with a large volume of IV therapies and, therefore, is the initial choice when dealing with hospitals, clinics, and specialty centers that deal with chronic and acute care.
Regional Insights
The intravenous infusion pump market in the United States of America is the largest around the globe because of the highly developed healthcare infrastructure, prevalence of chronic illnesses, strict safety laws and the early adoption of smart infusion technologies. This area is also characterized by well-developed reimbursement, large network of hospitals, and high levels of leading manufacturers that have stimulated incessant R&D and innovation.
In the meantime, the Asia Pacific market shows the greatest advancement in the intravenous infusion pump market because of the high number of patients, the increase in the burden of chronic diseases due to changes in lifestyles, urbanization and increased healthcare investments. Other developing nations such as China, India and Japan are experiencing an increment in the consumption of affordable and sophisticated pumps which are aided by the rising affordability, education and administration of modern health facilities. The market is further growing in Asia Pacific by economic progress and digital adoption of health.
Report Scope
| Feature of the Report | Details |
| Market Size in 2026 | USD 7.25 billion |
| Projected Market Size in 2035 | USD 14.02 billion |
| Market Size in 2025 | USD 6.72 billion |
| CAGR Growth Rate | 7.6% CAGR |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Key Segment | By Product Type, Disease Indication, End-User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Recent Developments
- In April 2025: ICU Medical received FDA 510(k) clearance for its new Plum Solo single-channel infusion pump and updated Plum Duo, expanding its IV Performance Platform with enhanced accuracy, data capabilities, and interoperability features. (Source: https://www.icumed.com/)
List of the prominent players in the Intravenous Infusion Pump Market:
- Becton Dickinson and Company (BD)
- Baxter International Inc.
- Braun Melsungen AG
- Fresenius Kabi AG
- ICU Medical Inc.
- Medtronic plc
- Terumo Corporation
- Tandem Diabetes Care Inc.
- Smiths Medical (ICU Medical)
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Others
The Intravenous Infusion Pump Market is segmented as follows:
By Product Type
- Volumetric Infusion Pumps
- Large Volume Pumps
- Small Volume Pumps
- Syringe Infusion Pumps
- Ambulatory Infusion Pumps
- Disposable Pumps
- Chemotherapy Infusion Pumps
- Patient-Controlled Analgesia (PCA) Pumps
- Implantable Infusion Pumps
- Insulin Infusion Pumps
- Infusion Pump Accessories and Consumables
By Disease Indication
- Chemotherapy
- Diabetes
- Gastroenterology
- Analgesia/Pain Management
- Pediatrics/Neonatology
- Hematology
- Other Applications
By End-User
- Hospitals
- Home Care Settings
- Ambulatory Care Centers
- Other End-Users
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America